It’s time to shatter the boundaries of traditional medicine, leverage the power of telemedicine and effectively tackle the ongoing challenges of chronic disease management.
Eye-opening statistics are the impetus for MediOrbis innovation:
For patients, health plans, self-insured employers and care providers, these statistics not only threaten individual health and well-being, but they can often devastate personal finances and business financial solvency. Fortunately, our approach to telemedicine is reaching new levels of patient engagement and efficiency in reducing the impact and cost of chronic disease management. Patients with chronic diseases account for 81% of all hospital admissions, which tend to be one of the most expensive aspects of care.
Our physician specialists can remotely monitor a patient’s condition, helping them to manage their treatment regime—and reducing their chances of being admitted or readmitted to the hospital.
We understand that chronic medical conditions are no longer simply “long-term” but “continuous.” That’s why we make it possible for patients to connect with a world-class medical specialist anytime, anywhere. This is particularly valuable for the estimated 57 million Americans currently living in a rural area and lacking access to care facilities.
Our chronic disease management (CDM) program is poised to become a standard 21st-century tool for communicating with patients with chronic disease. Our first-to-market capabilities for managing conditions, such as heart disease, chronic lung disease, diabetes and chronic kidney disease, enhance quality, improve outcomes and achieve cost savings.
We differentiate our programs with the use of sophisticated AI-powered software with clinical and telemedicine input. Grounded in continuous innovation, we develop meaningful strategies that impact the health and well-being of individuals while addressing the financial and fiduciary concerns of our growing customer base.